无针灸项目韩医治疗 versus 中西医结合治疗更年期障碍的成本效用分析:全国性回顾性队列研究
该研究利用韩国国民健康保险理赔数据(2015-2023),对32,941名更年期障碍女性进行回顾性队列分析,比较四种治疗策略的成本效用。结果显示,无针灸理赔的韩医治疗组成本最低且QALYs相对较高(2.11),其他策略均被支配(成本更高而QALYs略低);针灸使用者病程更长、合并症更多、医疗利用更高,提示病情更重。敏感性分析证实该优势稳健。
要点
- 无针灸理赔的韩医治疗在更年期障碍管理中成本最低且QALYs相对较高(2.11)。
- 含针灸或含西医的综合治疗组均被支配,成本更高而QALYs略低。
- 针灸使用者病情更重(病程长、合并症多、医疗利用高),综合治疗组的高成本可能反映疾病严重度而非疗效不足。
核心结论
- 在全国性队列中,无针灸理赔的韩医治疗是更年期障碍管理中最经济有利的策略。
- 综合治疗组观察到的更高医疗利用和成本可能反映疾病严重度更高,而非治疗无效。
研究设计与样本
- 回顾性队列研究,使用韩国国民健康保险理赔数据(2015-2023年)。
- 共纳入32,941名更年期障碍女性,按针灸和/或西医理赔记录分为四组:无针灸理赔的韩医治疗(参照组)、含针灸理赔的韩医治疗、无针灸理赔的韩医治疗加西医、含针灸理赔的韩医治疗加西医。
- 采用逆概率治疗加权(IPTW)估计增量成本效果比(ICERs),评估3年时间范围内的抑郁发生率和质量调整生命年(QALYs)。
- 敏感性分析调整贴现率和效用值。
主要发现
- 无针灸理赔的韩医治疗组成本最低且QALYs相对较高(2.11)。
- 含针灸理赔的韩医治疗、无针灸理赔的韩医治疗加西医、含针灸理赔的韩医治疗加西医三组均被支配(成本更高而QALYs略低)。
- 针灸使用者表现出更长的病程、更高的合并症率和更多的医疗利用。
- 敏感性分析证实无针灸理赔的韩医治疗的优势在所有情景下持续存在。
临床怎么用
- 对于更年期障碍患者,可优先考虑无针灸理赔的韩医治疗策略以优化成本效用。
- 临床决策时应考虑患者疾病严重度,综合治疗组的高成本可能反映病情更重而非疗效不足。
- 需个体化制定治疗策略,并进一步开展前瞻性研究以明确综合治疗方案的比较有效性和成本效果。
局限性
- 为回顾性队列研究,可能存在未测量的混杂因素。
- 使用理赔数据定义治疗策略,可能无法完全反映实际临床实践。
- 研究结论基于韩国特定医疗体系,外推至其他地区需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Menopausal women often experience both physical and psychological symptoms, including depression, which significantly impairs quality of life (QOL). While hormone replacement therapy (HRT) and antidepressants are common treatments, concerns over side effects have increased interest in Traditional Korean Medicine (TKM), especially acupuncture. However, real-world evidence comparing integrative treatment strategies is limited. METHODS: We conducted a retrospective cohort study using Korean National Health Insurance claims data (2015-2023) to evaluate the cost-utility of four treatment strategies for menopausal disorders, categorized by recorded claims for acupuncture (AP) and/or Western medicine (WM): TKM care without acupuncture claims (reference), TKM care with acupuncture claims, TKM care plus Western medicine without acupuncture claims, and TKM care plus Western medicine with acupuncture claims. Depression incidence and quality-adjusted life years (QALYs) were assessed over a 3-year horizon. Incremental cost-effectiveness ratios (ICERs) were estimated using inverse probability of treatment weighting (IPTW). Sensitivity analyses varied discount rates and utility values. RESULTS: Among 32,941 women, the TKM care without acupuncture claims group demonstrated the lowest costs and relatively higher QALYs (2.11). All other strategies-TKM care with acupuncture claims (TKM+AP), TKM care plus Western medicine without acupuncture claims (TKM+WM), and TKM care plus Western medicine with acupuncture claims (TKM+WM+AP)-were dominated, with higher costs but slightly lower QALYs. Acupuncture users exhibited longer episode durations, higher comorbidity rates, and greater healthcare utilization, suggesting a more severe underlying patient population. Sensitivity analyses confirmed that the dominance of TKM care without acupuncture claims persisted across all scenarios. CONCLUSION: In this nationwide cohort, TKM care without acupuncture claims emerged as the most economically favorable strategy for managing menopausal disorders. However, the higher utilization and costs observed in integrative care groups likely reflect greater disease severity rather than inefficacy. These findings highlight the need for individualized treatment strategies and further prospective research to clarify the comparative effectiveness and cost-effectiveness of integrative approaches.
引用
- Lee JY, Kim JU, Bae KH, et al. Cost-utility analysis of traditional Korean medicine without acupuncture claims versus integrative care for menopausal disorders: A nationwide retrospective cohort study. Integr Med Res. 2026. PMID: 41938894. doi:10.1016/j.imr.2026.101315
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。